Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Nantworks LLC
Headquarters: Los Angeles, CA, United States of America
Website: http://www.nantworks.com
Year Founded: 2011
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Dec 13, 2022
Product Development
Dec. 12 Quick Takes: Setbacks at ASH for Adicet and Lava
Plus: Updates from Magenta, CSL, Hemgenix, Affimed, Kymera and more
BioCentury | Feb 18, 2022
Politics, Policy & Law
Emails highlight Collins’ dedication to public-private partnerships
Documents released under FOIA also reveal efforts to prevent Trump from nominating Soon-Shiong as NIH director
BioCentury | Aug 17, 2021
Management Tracks
Spark alum Couto joins Atsena as CSO
Plus: Novavax, ImmunityBio, Freeline, ReCode, Yumanity
BioCentury | Sep 12, 2019
Distillery Therapeutics
Tumor-targeted serum albumin-chemotherapy conjugates for improved delivery to breast and colorectal cancers
BioCentury | Apr 12, 2019
Company News
Sorrento sues NantWorks' Soon-Shiong over alleged 'catch and kill' scheme
BioCentury | Jun 21, 2018
Product R&D
Tusk’s take on CD25
How Tusk is bringing CD25 mAbs back into cancer
BioCentury | Jun 9, 2018
Product Development
POC for cytokines
Cytokines are emerging as a logical combination partner to boost PD-1 responses
Items per page:
1 - 10 of 61